Investment Summary |
|
|---|---|
| Date | 2023-01-09 |
| Target | Sanguine BioSciences |
| Sector | Life Science |
| Investor(s) | The BroadOak Fund |
| Deal Type | Venture |
SEARCH BY
The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.
| DEAL STATS | # |
|---|---|
| Overall | 25 of 26 |
| Sector: Life Science M&A | 20 of 21 |
| Type: Venture M&A Deals | 7 of 7 |
| State: Massachusetts M&A | 2 of 2 |
| Country: United States M&A | 23 of 24 |
| Year: 2023 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-09 |
CDI Laboratories
Mayaguez, Puerto Rico CDI Laboratories is the nextGen proteomics company, a result of intensive efforts and advances made by synthetic biologists at the Johns Hopkins University School of Medicine. The company was created by scientists for scientists to address critical needs required accelerate research, advance discoveries, and translate these discoveries into novel products and services that improve human health. CDI Laboratories is based in Mayaguez, Puerto Rico. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-23 |
Emvenio Research
Durham, North Carolina, United States Emvenio Research is a decentralized research organization (DRO) providing scalable and hybrid decentralized trial solutions with a focus on improving access and health equity in clinical research. Emvenio Research is based in Durham, North Carolina. |
Sell | - |
